212
views
1
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      How to conduct a freedom-to-operate analysis for a drug repurposing project

      Preprint
      In review
      research-article
        1 ,
      DrugRxiv
      REPO4EU
      drug repurposing, intellectual property, patent searches, freedom to operate
      Bookmark

            Abstract

            This document provides the general methodology and specific resource access points for performing a Freedom to Operate (FtO) analysis tailored to the needs of a drug repurposing project. It has been deliberately written to be performed with minimal technical resources: only web access is required, and no use is made of artificial intelligence tools. It can be performed by the inventors, up to the point where potentially critical findings (if any) are discussed with a patent attorney. When done properly, this method actually improves the relevance of the analysis, since no patent specialist can be expected to be fully familiar with all the scientific aspects of a repurposing project.While patent searches are the dominant motive, there is also discussion of how to recruit suitable suppliers, an issue that is particularly important when the compound is reformulated (as will be the case in most cases).

            Content

            Author and article information

            Journal
            DrugRxiv
            REPO4EU
            10 December 2023
            Affiliations
            [1 ] H.M. Pharma Consultancy;
            Author notes
            Author information
            https://orcid.org/0000-0002-1491-6250
            Article
            10.58647/DRUGARXIV.PR000004.v1
            ed6fc2a7-6c19-4615-83cc-19aae68c9bfb

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            History
            : 10 December 2023
            Funding
            Funded by: funder-id http://dx.doi.org/10.13039/501100000780, European Commission;
            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Medicine
            drug repurposing,intellectual property,patent searches,freedom to operate

            Comments

            Comment on this article